Logo image of MYRG

MYR GROUP INC/DELAWARE (MYRG) Stock Fundamental Analysis

NASDAQ:MYRG - Nasdaq - US55405W1045 - Common Stock - Currency: USD

182.4  -4.41 (-2.36%)

After market: 182.4 0 (0%)

Fundamental Rating

5

Taking everything into account, MYRG scores 5 out of 10 in our fundamental rating. MYRG was compared to 52 industry peers in the Construction & Engineering industry. No worries on liquidiy or solvency for MYRG as it has an excellent financial health rating, but there are worries on the profitability. MYRG has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MYRG was profitable.
In the past year MYRG had a positive cash flow from operations.
In the past 5 years MYRG has always been profitable.
Each year in the past 5 years MYRG had a positive operating cash flow.
MYRG Yearly Net Income VS EBIT VS OCF VS FCFMYRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.28%, MYRG is in line with its industry, outperforming 50.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.31%, MYRG is in line with its industry, outperforming 53.85% of the companies in the same industry.
MYRG has a Return On Invested Capital of 5.07%. This is comparable to the rest of the industry: MYRG outperforms 53.85% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MYRG is significantly below the industry average of 16.67%.
Industry RankSector Rank
ROA 2.28%
ROE 6.31%
ROIC 5.07%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
MYRG Yearly ROA, ROE, ROICMYRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

MYRG's Profit Margin of 1.02% is in line compared to the rest of the industry. MYRG outperforms 46.15% of its industry peers.
MYRG's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 1.71%, MYRG perfoms like the industry average, outperforming 40.38% of the companies in the same industry.
In the last couple of years the Operating Margin of MYRG has declined.
MYRG's Gross Margin of 8.90% is on the low side compared to the rest of the industry. MYRG is outperformed by 67.31% of its industry peers.
MYRG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.71%
PM (TTM) 1.02%
GM 8.9%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
MYRG Yearly Profit, Operating, Gross MarginsMYRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

7

2. Health

2.1 Basic Checks

MYRG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MYRG has less shares outstanding than it did 1 year ago.
MYRG has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MYRG is higher compared to a year ago.
MYRG Yearly Shares OutstandingMYRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MYRG Yearly Total Debt VS Total AssetsMYRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

MYRG has an Altman-Z score of 4.65. This indicates that MYRG is financially healthy and has little risk of bankruptcy at the moment.
MYRG has a Altman-Z score of 4.65. This is in the better half of the industry: MYRG outperforms 71.15% of its industry peers.
MYRG has a debt to FCF ratio of 0.90. This is a very positive value and a sign of high solvency as it would only need 0.90 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.90, MYRG belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
MYRG has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
MYRG's Debt to Equity ratio of 0.15 is fine compared to the rest of the industry. MYRG outperforms 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.9
Altman-Z 4.65
ROIC/WACC0.49
WACC10.37%
MYRG Yearly LT Debt VS Equity VS FCFMYRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

MYRG has a Current Ratio of 1.31. This is a normal value and indicates that MYRG is financially healthy and should not expect problems in meeting its short term obligations.
MYRG has a Current ratio (1.31) which is in line with its industry peers.
A Quick Ratio of 1.31 indicates that MYRG should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.31, MYRG is doing good in the industry, outperforming 63.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
MYRG Yearly Current Assets VS Current LiabilitesMYRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for MYRG have decreased strongly by -27.52% in the last year.
The Earnings Per Share has been growing by 8.67% on average over the past years. This is quite good.
MYRG shows a decrease in Revenue. In the last year, the revenue decreased by -7.33%.
Measured over the past years, MYRG shows a quite strong growth in Revenue. The Revenue has been growing by 10.17% on average per year.
EPS 1Y (TTM)-27.52%
EPS 3Y-11.74%
EPS 5Y8.67%
EPS Q2Q%29.46%
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%2.21%

3.2 Future

Based on estimates for the next years, MYRG will show a very strong growth in Earnings Per Share. The EPS will grow by 45.56% on average per year.
Based on estimates for the next years, MYRG will show a small growth in Revenue. The Revenue will grow by 6.94% on average per year.
EPS Next Y98.62%
EPS Next 2Y55.25%
EPS Next 3Y45.56%
EPS Next 5YN/A
Revenue Next Year2.75%
Revenue Next 2Y4.43%
Revenue Next 3Y6.94%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MYRG Yearly Revenue VS EstimatesMYRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
MYRG Yearly EPS VS EstimatesMYRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 48.77, MYRG can be considered very expensive at the moment.
MYRG's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of MYRG to the average of the S&P500 Index (27.30), we can say MYRG is valued expensively.
The Price/Forward Earnings ratio is 22.19, which indicates a rather expensive current valuation of MYRG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MYRG indicates a somewhat cheap valuation: MYRG is cheaper than 65.38% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of MYRG to the average of the S&P500 Index (21.76), we can say MYRG is valued inline with the index average.
Industry RankSector Rank
PE 48.77
Fwd PE 22.19
MYRG Price Earnings VS Forward Price EarningsMYRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MYRG.
Based on the Price/Free Cash Flow ratio, MYRG is valued a bit cheaper than the industry average as 63.46% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 28.45
EV/EBITDA 23.62
MYRG Per share dataMYRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MYRG's earnings are expected to grow with 45.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.49
PEG (5Y)5.62
EPS Next 2Y55.25%
EPS Next 3Y45.56%

0

5. Dividend

5.1 Amount

No dividends for MYRG!.
Industry RankSector Rank
Dividend Yield N/A

MYR GROUP INC/DELAWARE

NASDAQ:MYRG (7/8/2025, 8:00:01 PM)

After market: 182.4 0 (0%)

182.4

-4.41 (-2.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-23 2025-07-23/amc
Inst Owners102.9%
Inst Owner Change-0.17%
Ins Owners1.75%
Ins Owner Change2.83%
Market Cap2.83B
Analysts85.45
Price Target173.2 (-5.04%)
Short Float %4.94%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.89%
Min EPS beat(2)18.63%
Max EPS beat(2)39.15%
EPS beat(4)4
Avg EPS beat(4)56.53%
Min EPS beat(4)18.63%
Max EPS beat(4)84.18%
EPS beat(8)5
Avg EPS beat(8)26.57%
EPS beat(12)7
Avg EPS beat(12)22.39%
EPS beat(16)11
Avg EPS beat(16)20.01%
Revenue beat(2)1
Avg Revenue beat(2)-2.13%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)3.99%
Revenue beat(4)1
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)3.99%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)8
Avg Revenue beat(12)3.22%
Revenue beat(16)11
Avg Revenue beat(16)3%
PT rev (1m)6.68%
PT rev (3m)11.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.29%
EPS NY rev (1m)3.78%
EPS NY rev (3m)8.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.64%
Revenue NY rev (1m)1.04%
Revenue NY rev (3m)1.39%
Valuation
Industry RankSector Rank
PE 48.77
Fwd PE 22.19
P/S 0.84
P/FCF 28.45
P/OCF 17.4
P/B 5.16
P/tB 7.84
EV/EBITDA 23.62
EPS(TTM)3.74
EY2.05%
EPS(NY)8.22
Fwd EY4.51%
FCF(TTM)6.41
FCFY3.51%
OCF(TTM)10.48
OCFY5.75%
SpS217.81
BVpS35.35
TBVpS23.27
PEG (NY)0.49
PEG (5Y)5.62
Profitability
Industry RankSector Rank
ROA 2.28%
ROE 6.31%
ROCE 7.36%
ROIC 5.07%
ROICexc 5.14%
ROICexgc 6.79%
OM 1.71%
PM (TTM) 1.02%
GM 8.9%
FCFM 2.94%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
ROICexc(3y)8.68%
ROICexc(5y)10.33%
ROICexgc(3y)11.86%
ROICexgc(5y)13.66%
ROCE(3y)12.04%
ROCE(5y)13.96%
ROICexcg growth 3Y-34.99%
ROICexcg growth 5Y-7.87%
ROICexc growth 3Y-35.45%
ROICexc growth 5Y-8.52%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
F-Score4
Asset Turnover2.22
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.9
Debt/EBITDA 0.69
Cap/Depr 96.44%
Cap/Sales 1.87%
Interest Coverage 250
Cash Conversion 132.09%
Profit Quality 287.28%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 4.65
F-Score4
WACC10.37%
ROIC/WACC0.49
Cap/Depr(3y)130.75%
Cap/Depr(5y)120.21%
Cap/Sales(3y)2.38%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.52%
EPS 3Y-11.74%
EPS 5Y8.67%
EPS Q2Q%29.46%
EPS Next Y98.62%
EPS Next 2Y55.25%
EPS Next 3Y45.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%2.21%
Revenue Next Year2.75%
Revenue Next 2Y4.43%
Revenue Next 3Y6.94%
Revenue Next 5YN/A
EBIT growth 1Y-52.55%
EBIT growth 3Y-25.77%
EBIT growth 5Y-2.54%
EBIT Next Year383.08%
EBIT Next 3Y83.95%
EBIT Next 5YN/A
FCF growth 1Y-1.05%
FCF growth 3Y-49.12%
FCF growth 5Y9.5%
OCF growth 1Y-11.17%
OCF growth 3Y-14.06%
OCF growth 5Y6.06%